Literature DB >> 21129806

NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism.

Chao-Wen Cheng1, Caroline C Duwaerts, Nico van Rooijen, Philip Wintermeyer, Stephanie Mott, Stephen H Gregory.   

Abstract

BACKGROUND & AIMS: Natural killer (NK) cells are innate immune effector cells first characterized by their ability to lyse susceptible tumor cells. Recent studies demonstrated their role in initiating and modulating adaptive immunity. NK cells represent a larger percentage of the lymphoid population in liver than other organs, suggesting that hepatic NK cells express some unique function. Here, we examined the response of NK cells to liver injury that occurs in a mouse model of biliary obstruction.
METHODS: Bile duct ligations (BDL) were performed in mice previously depleted or not depleted of NK cells. NK cell activation, interleukin (IL)-6 mRNA expression and protein production by Kupffer cells, and the ability of exogenous IL-6 to ameliorate liver injury in NK cell-depleted mice, were determined.
RESULTS: The number of activated hepatic NK cells increased markedly following BDL. Activation was suppressed in mice rendered Kupffer cell-depleted prior to ligation. Increased liver injury occurred in NK cell-depleted mice correlating with a reduction in IL-6 production. Purified Kupffer cells, obtained from NK cell-depleted or anti-interferon (IFN)-γ monoclonal antibody-pretreated mice following BDL, produced less IL-6 in culture than did Kupffer cells derived from control animals. In culture, hepatic NK cells derived from BDL mice stimulated IFN-γ-dependent IL-6 production by Kupffer cells; splenic NK cells obtained from the same animals had a negligible effect. Treatment with recombinant murine IL-6 reduced liver injury in BDL, NK cell-depleted mice.
CONCLUSIONS: Hepatic NK cells suppress cholestatic liver injury by stimulating Kupffer cell-dependent IL-6 production.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129806      PMCID: PMC3060960          DOI: 10.1016/j.jhep.2010.07.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

1.  Natural killer cell activation primes macrophages to clear bacterial infection.

Authors:  Melanie J Scott; J Jason Hoth; Sarah A Gardner; James C Peyton; William G Cheadle
Journal:  Am Surg       Date:  2003-08       Impact factor: 0.688

Review 2.  The composition of intrahepatic lymphocytes: shaped by selective recruitment?

Authors:  Katja Klugewitz; David H Adams; Masashi Emoto; Katharina Eulenburg; Alf Hamann
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

3.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

4.  The role of Kupffer cells in the differentiation process of hepatic natural killer cells.

Authors:  K Vanderkerken; L Bouwens; N Van Rooijen; K Van den Berg; M Baekeland; E Wisse
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

5.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Authors:  R B Herberman; M E Nunn; H T Holden; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

6.  Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils.

Authors:  S H Gregory; A J Sagnimeni; E J Wing
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

7.  Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.

Authors:  Jaspreet S Gujral; Jie Liu; Anwar Farhood; Hartmut Jaeschke
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

8.  Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.

Authors:  Marieke H Schoemaker; Willemijn M Gommans; Laura Conde de la Rosa; Manon Homan; Pieter Klok; Christian Trautwein; Harry van Goor; Klaas Poelstra; Hidde J Haisma; Peter L M Jansen; Han Moshage
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

9.  Impaired immune and acute-phase responses in interleukin-6-deficient mice.

Authors:  M Kopf; H Baumann; G Freer; M Freudenberg; M Lamers; T Kishimoto; R Zinkernagel; H Bluethmann; G Köhler
Journal:  Nature       Date:  1994-03-24       Impact factor: 49.962

10.  The role of intestinal flora on the interactions between nonparenchymal cells and hepatocytes in coculture.

Authors:  T R Billiar; M A Maddaus; M A West; D L Dunn; R L Simmons
Journal:  J Surg Res       Date:  1988-04       Impact factor: 2.192

View more
  14 in total

Review 1.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

2.  Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes.

Authors:  Tsukasa Nabekura; Luke Riggan; Andrew D Hildreth; Timothy E O'Sullivan; Akira Shibuya
Journal:  Immunity       Date:  2019-12-03       Impact factor: 31.745

3.  Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Authors:  Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz
Journal:  J Leukoc Biol       Date:  2013-07-24       Impact factor: 4.962

Review 4.  Innate immunity in alcoholic liver disease.

Authors:  Bin Gao; Ekihiro Seki; David A Brenner; Scott Friedman; Jessica I Cohen; Laura Nagy; Gyongyi Szabo; Samir Zakhari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

Review 5.  Mechanisms of bile acid mediated inflammation in the liver.

Authors:  Man Li; Shi-Ying Cai; James L Boyer
Journal:  Mol Aspects Med       Date:  2017-07-01

6.  Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells.

Authors:  Zhi-Bin Zhao; Fang-Ting Lu; Hong-Di Ma; Yin-Hu Wang; Wei Yang; Jie Long; Qi Miao; Weici Zhang; Zhigang Tian; William M Ridgway; Jie Cao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

7.  The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach.

Authors:  Faezeh Hosseinzadeh; Jafar Ai; Abbas Hajifathali; Samad Muhammadnejad; Somayeh Ebrahimi-Barough; Iman Seyhoun; Tahereh Komeili Movahed; Sadegh Shirian; Fatemeh Hosseinzadeh; Sajjad Ahmadpour; Mohammadreza Alijani; Javad Verdi
Journal:  Pharmacol Rep       Date:  2022-01-28       Impact factor: 3.024

8.  Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury.

Authors:  Caroline C Duwaerts; Stephan Gehring; Chao-Wen Cheng; Nico van Rooijen; Stephen H Gregory
Journal:  Liver Int       Date:  2012-12-13       Impact factor: 5.828

Review 9.  Natural killer cells in liver disease.

Authors:  Zhigang Tian; Yongyan Chen; Bin Gao
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

10.  Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.

Authors:  Celeste C Goh; Krystal M Roggerson; Hai-Chon Lee; Lucy Golden-Mason; Hugo R Rosen; Young S Hahn
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.